# Venus-Vitae Pivotal Study Smart-Align Study

> **NCT05991271** · NA · NOT_YET_RECRUITING · sponsor: **Venus MedTech (HangZhou) Inc.** · enrollment: 150 (estimated)

## Conditions studied

- Aortic Valve Stenosis

## Interventions

- **DEVICE:** Venus-Vitae Transcatheter Heart Valve System

## Key facts

- **NCT ID:** NCT05991271
- **Lead sponsor:** Venus MedTech (HangZhou) Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2023-10-31
- **Primary completion:** 2024-12-31
- **Final completion:** 2029-06-30
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2023-08-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05991271

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05991271, "Venus-Vitae Pivotal Study Smart-Align Study". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05991271. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*